Selected article for: "high mutation rate and mutation rate"

Author: Karch, Christopher P; Matyas, Gary R; Burkhard, Peter; Beck, Zoltan
Title: Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine
  • Document date: 2019_1_10
  • ID: yhh3ydok_1
    Snippet: The only surface protein of human immunodeficiency virus-1 (HIV-1) is the Env fusion protein. Env is heavily glycosylated, with glycans composing up to half of its mass [19] . During maturation of Env, the full-length gp160 is cleaved by a protease into gp41 and gp120, which remain associated forming Env heterodimers. Three heterodimers form a trimeric spike, and approximately 14 spikes decorate the surface of the virus [20, 21] . The majority, a.....
    Document: The only surface protein of human immunodeficiency virus-1 (HIV-1) is the Env fusion protein. Env is heavily glycosylated, with glycans composing up to half of its mass [19] . During maturation of Env, the full-length gp160 is cleaved by a protease into gp41 and gp120, which remain associated forming Env heterodimers. Three heterodimers form a trimeric spike, and approximately 14 spikes decorate the surface of the virus [20, 21] . The majority, about 62-79% of the gp120 glycans present on virus, are underprocessed N-linked high mannose, because the high density of the glycosylation sites can prevent the further processing steps of the glycans by the enzymes in the Golgi apparatus [22] . Changes in the glycosylation pattern of gp120 can alter the receptor binding and infection by the virus, as well as the susceptibility to antibodies [23, 24] . In addition, the high mutation rate of HIV-1 results in an inconsistent level of glycosylation. For example, transmitter/founder viruses generally have a lower number of N-linked glycosylation sites than chronic viruses and appear to be more infectious [25] .

    Search related documents:
    Co phrase search for related documents
    • chronic virus and receptor binding: 1, 2, 3, 4, 5, 6
    • Env fusion protein and receptor binding: 1
    • fusion protein and low number: 1, 2, 3
    • fusion protein and receptor binding: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • glycosylation pattern and receptor binding: 1, 2, 3
    • glycosylation site and receptor binding: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • Golgi apparatus and receptor binding: 1, 2
    • Golgi apparatus enzyme and receptor binding: 1
    • high density and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • high density and receptor binding: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • high mannose and receptor binding: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • high mutation and receptor binding: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • human immunodeficiency and low number: 1
    • inconsistent level and low number: 1